Skip to main content
49°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Imago Biosciences Inc
(NQ:
IMGO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 10, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Imago Biosciences Inc
< Previous
1
2
Next >
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.
Via
InvestorPlace
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.
Via
InvestorPlace
Looking Into Imago BioSciences's Recent Short Interest
January 04, 2023
Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular...
Via
Benzinga
5 Most Expensive Health Care Stocks You Should Worry About
January 03, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
How Is The Market Feeling About Imago BioSciences?
December 09, 2022
Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 13.61% of all regular...
Via
Benzinga
Analyst Ratings for Imago BioSciences
November 28, 2022
Via
Benzinga
What 5 Analyst Ratings Have To Say About Imago BioSciences
November 22, 2022
Via
Benzinga
Expert Ratings for Imago BioSciences
November 22, 2022
Via
Benzinga
3 Dow Stocks to Take Seriously in 2023
November 29, 2022
The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
Via
Benzinga
Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday
November 22, 2022
Via
Benzinga
Nasdaq Down More Than 100 Points; Gold Falls 1%
November 21, 2022
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday.
Via
Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
November 22, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
November 21, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
During Monday's session, 50 stocks hit new 52-week highs.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 21, 2022
Via
Benzinga
OPEC Rumors, Energy Stocks Drag Wall Street
November 21, 2022
The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well.
Via
Talk Markets
Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher
November 21, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday.
Via
Benzinga
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
November 21, 2022
U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
November 21, 2022
Markets sent mixed messages to start out Thanksgiving week.
Via
The Motley Fool
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
November 21, 2022
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share.
Via
InvestorPlace
Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney
November 21, 2022
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday.
Via
Benzinga
Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout
November 21, 2022
Seagen who? Merck is putting its cash to work buying a smaller biotech company.
Via
Investor's Business Daily
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
November 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 21, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
Upgrades
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Imago BioSciences: Here's What You Need To Know
August 16, 2022
HC Wainwright & Co. has decided to maintain its Buy rating of Imago BioSciences (NASDAQ:IMGO) and lower its price target from $36.00 to $35.00. Shares of Imago BioSciences are trading down 2.8% over...
Via
Benzinga
70 Biggest Movers From Friday
May 02, 2022
Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)...
Via
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
Upgrades According to Mizuho, the prior rating for Murphy Oil Corp (NYSE:MUR) was changed from Neutral to Buy. In the fourth quarter, Murphy Oil showed an EPS of $0.40,...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.